Streetbeat News

Stock Prices

AMRX

Amneal Pharmaceuticals Inc (NASDAQ:AMRX) announced a settlement over $270 million to resolve U.S. opioid crisis-related lawsuits. The settlement includes $92.5 million in cash and $180 million in naloxone nasal spray, spread over ten years. This agreement aims to settle a significant portion of the over 900 opioid-related lawsuits against Amneal. Additionally, Amneal reported a Q1 adjusted EPS of $0.14, beating the consensus of $0.09, and sales of $659.2 million, up 8% from the previous year. The company reaffirms its FY 2024 revenue guidance of $2.55 billion-$2.65 billion and an adjusted EPS of $0.53-$0.63.

Portfolio Pulse from Vandana Singh

May 03, 2024 | 6:43 pm

PARA

PARAA

Paramount shares are trading lower after a report indicated that the company does not expect the Skydance or the Sony-Apollo offer to materialize.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 6:41 pm

PLTR

Palantir Technologies saw significant options trading activity with a sweep of 3,080 contracts for Friday $23 calls near the ask price of $0.371, against an open interest of 20,315. This activity comes ahead of their earnings report due on May 6th, after the market closes, with the reference stock price at $23.325.

Portfolio Pulse from Charles Gross

May 03, 2024 | 6:34 pm

AMAT

Deep-pocketed investors have shown a significant interest in Applied Materials (NASDAQ:AMAT), with a mix of bullish and bearish sentiments based on options activity. Benzinga's tracking revealed 18 unusual options activities, with a price target range from $70.0 to $210.0. The current market status of AMAT shows a 3.32% increase in price at $204.49, with neutral RSI indicators. Analysts have set an average price target of $260.0, with mixed ratings from Evercore ISI Group and Cantor Fitzgerald.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:31 pm

ETSY

Financial analysis reveals a bullish sentiment in Etsy's options trading, with 61% of traders showing bullish tendencies. Significant investors target a price range of $40.0 to $100.0 for Etsy in the next three months. The analysis of options activity, including both calls and puts, provides insights into market sentiment and potential price movements. Etsy, a leading e-commerce marketplace, has shown a 1.27% increase in stock price, reaching $59.99, with an RSI indicating a potential oversold condition. Analyst ratings from firms like Oppenheimer, Guggenheim, Citigroup, Truist Securities, and B. Riley Securities offer varied price targets, with an average target price of $76.0.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:31 pm

COP

Deep-pocketed investors have shown a significant interest in ConocoPhillips (NYSE:COP), with a mix of bullish and bearish sentiments reflected in recent options trading activities. Benzinga's tracking revealed 11 unusual options activities, with a focus on a price band between $120.0 and $140.0. The trading volume and open interest suggest heightened activity, with a split sentiment among investors. ConocoPhillips, a major independent exploration and production firm, has seen its stock price slightly decrease by -0.61%, currently trading at $121.5. Analyst ratings remain positive, with a consensus target price of $153.4.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:31 pm

AEON

HSY

OMI

SGBX

SPT

TNDM

UPLD

U.S. stocks saw significant gains with the S&P 500 rising over 1%, led by a strong performance in the information technology sector. Hershey Company reported better-than-expected earnings, boosting its stock. Meanwhile, Safe & Green Holdings, Upland Software, and Tandem Diabetes Care saw substantial increases in their share prices following positive financial results. Conversely, AEON Biopharma, Sprout Social, and Owens & Minor experienced sharp declines due to disappointing financial outcomes or trial results.

Portfolio Pulse from Avi Kapoor

May 03, 2024 | 6:30 pm

TXT

Over the past 15 years, Textron (NYSE:TXT) has delivered an average annual return of 14.23%, turning a $1000 investment into $7,158.03 today. With a current market capitalization of $16.33 billion, Textron's performance highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:30 pm

TMO

Thermo Fisher Scientific (NYSE:TMO) has delivered an average annual return of 16.16% over the past 20 years, outperforming the market by 8.16%. A $100 investment in TMO 20 years ago would be worth $2,069.22 today. The company's current market capitalization stands at $219.66 billion.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 6:30 pm

TXRH

BTIG analyst Peter Saleh maintains a Buy rating on Texas Roadhouse (TXRH) and raises the price target from $155 to $175, indicating a positive outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 6:30 pm